Trial · NCT03226067
Adverse events72
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 72
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dry Mouth | Gastrointestinal disorders | Placebo Arm | 2 | 37 | 2 |
| other | Abdominal Distension | Gastrointestinal disorders | GKT137831 400mg Twice Daily | 2 | 36 | 2 |
| other | Abdominal Distension | Gastrointestinal disorders | GKT137831 400mg Once Daily | 0 | 38 | 0 |
| other | Abdominal Distension | Gastrointestinal disorders | Placebo Arm | 0 | 37 | 0 |
| other | Pruritis | Skin and subcutaneous tissue disorders | GKT137831 400mg Twice Daily | 8 | 36 | 10 |
| other | Pruritis | Skin and subcutaneous tissue disorders | GKT137831 400mg Once Daily | 8 | 38 | 11 |
| other | Pruritis | Skin and subcutaneous tissue disorders | Placebo Arm | 8 | 37 | 8 |
| other | Alopecia | Skin and subcutaneous tissue disorders | GKT137831 400mg Twice Daily | 1 | 36 | 1 |
| other | Alopecia | Skin and subcutaneous tissue disorders | GKT137831 400mg Once Daily | 0 | 38 | 0 |
| other | Alopecia | Skin and subcutaneous tissue disorders | Placebo Arm | 2 | 37 | 2 |
| other | Nasopharyngitis | Immune system disorders | GKT137831 400mg Twice Daily | 1 | 36 | 1 |
| other | Nasopharyngitis | Immune system disorders | GKT137831 400mg Once Daily | 3 | 38 | 3 |
| other | Nasopharyngitis | Immune system disorders | Placebo Arm | 3 | 37 | 5 |
| other | Urinary Tract Infection | Infections and infestations | GKT137831 400mg Twice Daily | 2 | 36 | 2 |
| other | Urinary Tract Infection | Infections and infestations | GKT137831 400mg Once Daily | 0 | 38 | 0 |
| other | Urinary Tract Infection | Infections and infestations | Placebo Arm | 4 | 37 | 5 |
| other | Upper Respiratory Tract Infection | Infections and infestations | GKT137831 400mg Twice Daily | 2 | 36 | 2 |
| other | Upper Respiratory Tract Infection | Infections and infestations | GKT137831 400mg Once Daily | 0 | 38 | 0 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Placebo Arm | 2 | 37 | 2 |
| other | Oral Herpes | Infections and infestations | GKT137831 400mg Twice Daily | 1 | 36 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03226067/events?page=2